Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Ekaterina Andreevna Snigir has a total of 123 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Hidden burden of chronic non-communicable diseases. Part 2: prevalence of germline variants associated with cancers among residents of the Russian Federation

    by V. S. Yudin, A. A. Mamchur, E. A. Nikolaeva, M. V. Ivanov, D. A. Kashtanova, E. A. Zelenova, S. I. Mitrofanov, Е. А. Снигирь, Л. П. Кузьмина, A. A. Keskinov

    Introduction. Cancer is a leading cause of mortality worldwide. Hereditary (germline) mutations in cancer predisposition genes significantly contribute to oncogenesis (accounting for 3–12.6% of adult cases). Identifying carriers of pathogenic/likely pathogenic (P/LP) variants is crucial for cancer prevention and its early detection. Large-scale data on the prevalence of such variants in the general population of the Russian Federation, essential for healthcare resource planning, have been extremely limited until now. Objective. To assess the prevalence and spectrum of pathogenic and likely pathogenic germline variants in genes associated with cancer risk in a Russian population cohort. Materials and methods. An analysis of whole-genome sequencing data from 116,794 participants (a representative sample of the adult population from 86 federal subjects of the Russian Federation) was conducted. The search for P/LP variants in cancer-associated genes was performed based on the ClinVar database. Variant annotation was carried out considering the level of evidence. Statistical analysis was performed using Python (v3.9.12). Results. P/LP variants were identified in 26 cancer-associated genes among 2643 participants (2.26%). The most frequent variant was rs36053993 ( MUTYH , 0.28%), with its frequency in the Russian Federation being lower than in global databases (ALFA, gnomAD). Level A variants (only those with the “reviewed by expert panel” level of evidence) were carried by 0.8% of individuals collectively. Level B variants (those with the “reviewed by expert panel” and “criteria provided, multiple submitters, no conflicts” levels of evidence) were carried by 2.08%. The inclusion of less reliable evidence levels (C, D) increased this proportion only marginally, to 2.26%. A statistically significant decrease in the proportion of carriers of Level A variants with age was observed ( p = 0.007), while the overall proportion of P/LP variant carriers decreased only slightly ( p = 0.17). Substantial geographical variability in prevalence was identified, ranging from 865 (Bashkortostan) to 6250 (Chechnia) variants per 100,000 population. In Moscow, the prevalence was 2340 per 100,000. Conclusions. The study revealed a significant “hidden burden” of P/LP oncogenic germline variant carriers (2.26%) in the Russian population. The primary burden is attributed to variants with a high level of evidence (Level B). The substantial variability in prevalence across regions of the Russian Federation necessitates a differentiated approach to healthcare resource planning. The data obtained substantiate the need for implementing genetic screening programs (especially for individuals with a family history) and enhanced oncological surveillance for carriers. This represents a strategic direction for reducing cancer incidence and mortality in high genetic risk groups within the Russian Federation.

  • Open Access

    Pharmacogenetic factors determining the metabolism and safety of aromatic anticonvulsants in the residents of Russia

    by E. D. Spektor, V. S. Yudin, A. A. Mamchur, A. M. Rumyantseva, M. V. Ivanov, S. I. Mitrofanov, E. A. Snigir, A. A. Keskinov, S. M. Yudin, D. A. Kashtanova

    Introduction. The use of aromatic anticonvulsants (carbamazepine, oxcarbazepine, lamotrigine, and phenytoin) is associated with the risk of severe hypersensitivity reactions, which are partly dependent on HLA-B and HLA-A genotypes (for carbamazepine/oxcarbazepine). Phenytoin and fosphenytoin are metabolized by CYP2C9 ; therefore, in the setting of genetically determined impaired drug tolerability, the likelihood of adverse events increases. Consideration of the CYP2C9 genotype is important for developing personalized drug dosing schemes and improving treatment outcomes. Objective. Assessment of the prevalence of major pharmacogenetic variants associated with response to aromatic anticonvulsants, with geographic stratification and identification of at-risk populations warranting preemptive genotyping prior to treatment initiation. Materials and methods. The study was performed using samples from the Population Frequency Database (GDB) of the Federal Medical and Biological Agency (FMBA) of Russia ( n = 120,979, covering 82 RF subjects). Whole-genome sequencing of DNA samples was conducted followed by an analysis of the carrier frequency of HLA-B*15:02 , HLA-B*15:11 , HLA-A*31:01 , and various allelic variants of CYP2C9 with calculation of the enzyme activity score. These metrics were compared across different Russian regions, identifying high-risk biogeographic groups. Results. The HLA-B*15:02 variant showed a prevalence of less than 1% in all regions of the Russian Federation. A relatively high carrier frequency of HLA-B*15:11 was observed in the Republics of Buryatia and Tyva (1.3%, p = 7.7 × 10 –5 and 3.46%, p = 2.4 × 10 –3 , respectively, compared to a population frequency of 0.11%). The elevated frequencies of HLA-A*31:01 were detected in Perm Krai and the Republics of Kalmykia, Buryatia, Tyva, and Sakha (Yakutia) (8.48%, p = 0.042; 8.79%, p = 0.044; 10.3%, p = 3.4 × 10 –10 ; 20.44%, p = 3.4 × 10 –10 ; 28.74%, p = 5.4 × 10 –122 , respectively, compared to a population frequency of 5.06%). The Republics of Dagestan, Ingushetia, and Kabardino-Balkaria showed a higher prevalence of impaired metabolism phenotype for phenytoin/phosphenytoin (46.4%, p = 5.6 × 10 –36 ; 44.69%, p = 1.7 × 10 –13 ; 43.83%, p = 1.9 × 10 –16 ), primarily due to a high frequency of the CYP2C9*3 allele. The Republics of Tatarstan, Mari El, and Chuvashia were also characterized by a high incidence of alleles associated with impaired metabolism of these drugs (37.06%, p = 0.028; 37.99%, p = 0.031; 41.2%, p = 5.3 × 10 –10 ), attributable to the presence of the generally rare CYP2C9*29 allele in their genetic structure. Conclusions. The results obtained enable the formulation of region-specific recommendations for personalizing treatment with aromatic anticonvulsants. For residents of Sakha (Yakutia), Tyva, Buryatia, Kalmykia, and Perm Krai, testing for HLA-A*31:01 carriage is justified. For residents of Tyva and Buryatia, additional testing for HLA-B*15:11 carriage is warranted prior to the prescription of carbamazepine and oxcarbazepine. Before initiating phenytoin therapy, CYP2C9 genotyping is particularly important for the populations of Dagestan, Ingushetia, Kabardino-Balkaria, Tatarstan, Mari El, and Chuvashia. However, this genotyping can be recommended for the entire population of Russia due to the high prevalence of alleles associated with reduced and absent enzyme activity.


  • Open Access

    Analysis of HERV-K (HML2) Expression in Colorectal Cancer Samples

    by Valentina S. Obrezanenko, Polina M. Shulga, Anastasia G. Volkova, Anastasia A. Primova, Yulia A. Remizova, Ivan O. Meshkov, Alexandra D. Kikot, Daria A. Tarasova, Ekaterina S. Bolashova, Alexey A. Ivashechkin, et al.

    Background: HML-2 subgroup mobile genetic elements of the HERV-K family were described to participate in carcinogenesis processes, but their expression and epigenetic regulation in molecular subtypes of colorectal cancer (CRC) remain partly characterized. The present study aimed to evaluate the expression of HML-2 elements using RNA-sequencing data in paired tumor and normal intestinal tissue samples from 63 patients with CRC to identify patterns of the retrotransposons’ activity in different molecular subtypes (CMSs). Methods: RNA-sequencing and DNA methylation data were analyzed for paired CRC and normal tissue samples. HERV-K expression was assessed using three bioinformatics tools: Telescope (version 1.0.3), TEtranscripts (version 2.2.3), GeneTEFlow (version 2020). Molecular tumor subtypes were defined using the CMScaller (version 0.99.2) program. The results of the HML-2 loci expression analysis were supplemented with the HML-2 proteins expression data obtained by quantitative RT-PCR. Results: HML-2 expression assessment by GeneTEFlow (version 2020), TECount (version 2.2.3) and Telescope (version 1.0.3) showed high convergence: the Pearson correlation coefficient for each tool exceeded 0.88. Several HML-2 loci were identified as differentially expressed in CRC samples of different CMS. The PCR results confirmed an increase in HML-2 expression in tumor tissues. For all CMSs, an inverse association was detected between differential methylation of CpG sites and differential expression of HML-2 loci. Associations of HML-2 expressions with differentially expressed genes in which they are located were found, and for a number of such genes an inverse relationship between the expression level and the methylation level of their promoters were demonstrated, and data on the involvement in the pathogenesis of CRC were described: CR1, CD48, TTLL3, ABCC2 and ZNF420. Expression signatures associated with the activity of the RIG-I-like receptor signaling cascade were identified in CMS1–3 CRC samples, which may indicate the possible implementation of viral mimicry against the background of HML-2 activation. Conclusions: Analysis of the expression of HML-2 and its association with CpG methylation contributes to a comprehensive interpretation of the CRC pathogenesis mechanisms.


  • Open Access

    A comparative analysis of kits for nucleic acid extraction from animal blood and tissue samples

    by N. A. Kumar, D. A. Tarasova, A. A. Bukhanova, E. D. Maralova, O. Ya. Zimmer, R. A. Illarionov, A. A. Ivashechkin, N. B. Emelyanova, A. V. Makhotenko, V. B. Azaryan, et al.

    Aim . To conduct a comparative analysis of the effectiveness of com­mer­cial kits for deoxyribonucleic acid (DNA) extraction from blood and tissue, as well as ribonucleic acid (RNA) from mouse tissue, and to eva­luate the effect of the postmortem interval (PMI) on the quality and quan­tity of extracted nucleic acids (NA). Material and methods . Blood and tissue samples (brain, heart, liver, kid­neys, lungs, muscle, and testes) from 12 Balb/C mice were used. Samp­les were collected immediately (0 h) and 24 h after euthanasia. Ten commercial kits (Russian and international) were tested for DNA ex­trac­tion, and the RNeasy Mini Kit (Qiagen, Germany) was used for RNA extraction. Quality control included measuring the concen­tra­tion (fluorometry), purity (spectrophotometry), and integrity (electro­pho­resis) of the DNA. Results. Spin-column-­based kits (QIAamp DNA Blood Mini Kit, Qiagen, USA, D-Blood-5) demonstrated the highest DNA yield from blood. For tissue, magnetic particle kits (GM Tissue, Tissue M) provided the highest DNA yield, but the column-­based method (QIAamp DNA Mini Kit, Qiagen, Germany) yielded better purity and stability with increasing PMI. Increasing the PMI to 24 hours resulted in a significant decrease in the concentration and integrity of both DNA and RNA in all tissues except the testes. The most pronounced RNA degradation (a decrease in RNA integrity number to 2,5-2,8) was observed in the kidneys and muscles. Conclusion . The efficiency of NA isolation significantly depends on the type of kit, biomaterial, and PMI. The selection of the optimal method should be based on these factors. The data obtained are critical for planning the preanalytical stage of the study.

  • Open Access

    Interplay of the Genetic Variants and Allele Specific Methylation in the Context of a Single Human Genome Study

    by Maria D. Voronina, Olga V. Zayakina, Kseniia A. Deinichenko, Olga Sergeevna Shingalieva, Olga Y. Tsimmer, Darya A. Tarasova, Pavel Alekseevich Grebnev, Ekaterina A. Snigir, Sergey I. Mitrofanov, Vladimir S. Yudin, et al.

    The methylation of CpG sites with 5mC mark is a dynamic epigenetic modification. However, the relationship between the methylation and the surrounding genomic sequence context remains poorly explored. Investigation of the allele methylation provides an opportunity to decipher the interplay between differences in the primary DNA sequence and epigenetic variation. Here, we performed high-coverage long-read whole-genome direct DNA sequencing of one individual using Oxford Nanopore technology. We also used Illumina whole-genome sequencing of the parental genomes in order to identify allele-specific methylation sites with a trio-binning approach. We have compared the results of the haplotype-specific methylation detection and revealed that trio binning outperformed other approaches that do not take into account parental information. Also, we analysed the cis-regulatory effects of the genomic variations for influence on CpG methylation. To this end, we have used available Deep Learning models trained on the primary DNA sequence to score the cis-regulatory potential of the genomic loci. We evaluated the functional role of the allele-specific epigenetic changes with respect to gene expression using long-read Nanopore RNA sequencing. Our analysis revealed that the frequency of SNVs near allele-specific methylation positions is approximately four times higher compared to the biallelic methylation positions. In addition, we identified that allele-specific methylation sites are more conserved and enriched at the chromatin states corresponding to bivalent promoters and enhancers. Together, these findings suggest that significant impact on methylation can be encoded in the DNA sequence context. In order to elucidate the effect of the SNVs around sites of allele-specific methylation, we applied the Deep Learning model for detection of the cis-regulatory modules and estimated the impact that a genomic variant brings with respect to changes to the regulatory activity of a DNA loci. We revealed higher cis-regulatory impact variants near differentially methylated sites that we further coupled with transcriptomic long-read sequencing results. Our investigation also highlights technical aspects of allele methylation analysis and the impact of sequencing coverage on the accuracy of genomic phasing. In particular, increasing coverage above 30X does not lead to a significant improvement in allele-specific methylation discovery, and only the addition of trio binning information significantly improves phasing. We investigated genomic variation in a single human individual and coupled computational discovery of cis-regulatory modules with allele-specific methylation (ASM) profiling. In this proof-of-concept analysis, we observed that SNPs located near methylated CpG sites on the same haplotype were enriched for sequence features suggestive of high-impact regulatory potential. This finding—derived from one deeply sequenced genome—illustrates how phased genetic and epigenetic data analyses can jointly put forward a hypotheses about the involvement of regulatory protein machinery in shaping allele-specific epigenetic states. Our investigation provides a methodological framework and candidate loci for future studies of genomic imprinting and cis-mediated epigenetic regulation in humans.


  • Open Access

    The Association between Gut Microbiota and Serum Biomarkers in Children with Atopic Dermatitis

    by Irina G. Kalashnikova, Alexandra I. Nekrasova, Anna V. Korobeynikova, Maria M. Bobrova, German A. Ashniev, Sirozhdin Yu. Bakoev, Angelica V. Zagainova, Mariya V. Lukashina, Larisa R. Tolkacheva, Ekaterina S. Petryaikina, et al.

    Background. Currently, it is known that the gut microbiota plays an important role in the functioning of the immune system, and a rebalancing of the bacterial community can arouse complex immune reactions and lead to immune-mediated responses in an organism, in particular, the development of atopic dermatitis (AD). Cytokines and chemokines are regulators of the innate and adaptive immune response and represent the most important biomarkers of the immune system. It is known that changes in cytokine profiles are a hallmark of many diseases, including atopy. However, it remains unclear how the bacterial imbalance disrupts the function of the immune response in AD. Objectives. We attempted to determine the role of gut bacteria in modulating cytokine pathways and their role in atopic inflammation. Methods. We sequenced the 16S rRNA gene from 50 stool samples of children aged 3–12 years who had confirmed atopic dermatitis, and 50 samples from healthy children to serve as a control group. To evaluate the immune status, we conducted a multiplex immunofluorescence assay and measured the levels of 41 cytokines and chemokines in the serum of all participants. Results. To find out whether changes in the composition of the gut microbiota were significantly associated with changes in the level of inflammatory cytokines, a correlation was calculated between each pair of bacterial family and cytokine. In the AD group, 191 correlations were significant (Spearman’s correlation coefficient, p ≤ 0.05), 85 of which were positive and 106 which were negative. Conclusions. It has been demonstrated that intestinal dysbiosis is associated with alterations in cytokine profiles, specifically an increase in proinflammatory cytokine concentrations. This may indicate a systemic impact of these conditions, leading to an imbalance in the immune system’s response to the Th2 type. As a result, atopic conditions may develop. Additionally, a correlation between known AD biomarkers (IL-5, IL-8, IL-13, CCL22, IFN-γ, TNF-α) and alterations in the abundance of bacterial families (Pasteurellaceae, Barnesiellaceae, Eubacteriaceae) was observed.


  • Open Access

    Benchmarking of Approaches for Gene Copy-Number Variation Analysis and Its Utility for Genetic Aberration Detection in High-Grade Serous Ovarian Carcinomas

    by Pavel Alekseevich Grebnev, Ivan Olegovich Meshkov, Pavel Viktorovich Ershov, Antonida Viktorovna Makhotenko, Valentina Bogdanovna Azarian, Marina Vyacheslavovna Erokhina, Anastasiya Aleksandrovna Galeta, Aleksandr Vladimirovich Zakubanskiy, Olga Sergeevna Shingalieva, Anna Vasilevna Tregubova, et al.

    Objective: The goal of this study was to compare the results of CNV detection by three different methods using 13 paired carcinoma samples, as well as to perform a statistical analysis of the agreement. Methods: CNV was studied using NanoString nCounter v2 Cancer CN Assay (Nanostring), Illumina Infinium CoreExome microarrays (CoreExome microarrays) and digital droplet PCR (ddPCR). Results: There was a good level of agreement (PABAK score > 0.6) between the CoreExome microarrays and the ddPCR results for finding CNVs. There was a moderate level of agreement (PABAK values ≈ 0.3–0.6) between the NanoString Assay results and microarrays or ddPCR. For 83 out of 87 target genes studied (95%), the agreement between the CoreExome microarrays and NanoString nCounter was characterized by PABAK values < 0.75, except for MAGI3, PDGFRA, NKX2-1 and KDR genes (>0.75). The MET, HMGA2, KDR, C8orf4, PAX9, CDK6, and CCND2 genes had the highest agreement among all three approaches. Conclusions: Therefore, to get a better idea of how to genotype an unknown CNV spectrum in tumor or normal tissue samples that are very different molecularly, it makes sense to use at least two CNV detection methods. One of them, like ddPCR, should be able to quantitatively confirm the results of the other.


  • Open Access

    Genomic Signatures of Positive Selection in Human Populations of the OXT, OXTR, AVP, AVPR1A and AVR1B Gene Variants Related to the Regulation of Psychoemotional Response

    by Siroj Yu. Bakoev, Anna V. Korobeinikova, Arina I. Mishina, Shuanat Sh. Kabieva, Sergey I. Mitrofanov, Alexey A. Ivashechkin, Alexsandra I. Akinshina, Ekaterina A. Snigir, Sergey M. Yudin, Vladimir S. Yudin, et al.

    The neurobiological systems of maintenance and control of behavioral responses result from natural selection. We have analyzed the selection signatures for single nucleotide variants (SNV) of the genes of oxytocin (OXT, OXTR) and vasopressin (AVP, AVPR1A, AVPR1B) systems, which are associated with the regulation of social and emotional behavior in distinct populations. The analysis was performed using original WGS (whole genome sequencing) data on Eastern Slavs (SlEast), as well as publicly available data from the 1000 Genomes Project on GBR, FIN, IBR, PUR, BEB, CHB, and ACB populations (the latter were taken as reference). To identify selection signatures, we rated the integrated haplotype scores (iHS), the numbers of segregating sites by length (nSl), and the integrated haplotype homozygosity pooled (iHH12) measures; the fixation index Fst was implemented to assess genetic differentiation between populations. We revealed that the strongest genetic differentiation of populations was found with respect to the AVPR1B gene, with the greatest differentiation observed in GRB (Fst = 0.316) and CHB (Fst = 0.325) in comparison to ACB. Also, high Fst values were found for SNVs of the AVPR1B gene rs28499431, rs33940624, rs28477649, rs3883899, and rs28452187 in most of the populations. Selection signatures have also been identified in the AVP, AVPR1A, OXT, and OXTR genes. Our analysis shows that the OXT, OXTR, AVP, AVPR1A, and AVPR1B genes were subject to positive selection in a population-specific process, which was likely contributing to the diversity of adaptive emotional response types and social function realizations.


  • Comparison of WGS-based HLA typing bioinformatic tools

    by P.G. Kazakova, S.I. Mitrofanov, Yu.N. Akhmerova, O.V. Varlamova, P.Yu. Zemsky, A.A. Mkrtchian, A.P. Sergeev, E.A. Snigir, N.V. Feliz, L.V. Frolova, et al.

    Сравнение инструментов биоинформатики для HLA-типирования на основе данных WGS

  • Methodology for evaluation of the level of IgG antibodies against different SARS-CoV-2 proteins using multiplex immunofluorescence analysis

    by L.V. Frolova, P.Yu. Zemsky, S.I. Mitrofanov, V.E. Mukhin, T.а. Shpakova, P.G. Kazakova, Yu.N. Akhmerova, N.V. Bulanova, L.A. Golubnikova, K.S. Grammatikati, et al.

    Методика оценки уровня IgG-антител к различным белкам SARS-CoV-2 с помощью мультиплексного иммунофлуоресцентного анализа